about
Chlamydia trachomatis antigens in enteroendocrine cells and macrophages of the small bowel in patients with severe irritable bowel syndrome.No difference in small bowel microbiota between patients with irritable bowel syndrome and healthy controls.Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome.Prevalence of Eosinophilic Esophagitis and Lymphocytic Esophagitis in Adults with Esophageal Food Bolus Impaction.Human enteroendocrine cell responses to infection with Chlamydia trachomatis: a microarray study.Beyond white light endoscopy: the role of optical biopsy in inflammatory bowel disease.Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts.Increased Expression of Toll-Like Receptors 4, 5, and 9 in Small Bowel Mucosa from Patients with Irritable Bowel Syndrome.Immunocytochemical evaluation of gastric mucosal cathepsin D in peptic ulcer.Narrow-band imaging magnifying endoscopy in adult patients with eosinophilic esophagitis/esophageal eosinophilia and lymphocytic esophagitis.Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center StudyEcoRI polymorphism of the L-myc gene in gastric cancer patientsMesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease[Genetic alterations in gastric cancer][Telomerase and gastrointestinal cancer][Plasma prekallikrein in chronic liver diseases]Plasma prekallikrein levels in patients with hepatocellular carcinoma and liver cirrhosis: a pilot study
P50
Q33531535-8B76D990-A816-47E7-B94C-825422BC60B7Q35089445-EA30BC89-0C1C-4E2E-85B3-6BAFFF910742Q35781494-6FA60E44-6DA5-43AD-B772-325B65FF750FQ37166333-F84BD688-A01C-44BF-8392-0F43DF4E10D8Q37844108-9EF8F163-1C16-4F84-A7DB-03EFCC9491DAQ38166709-D36DD12E-F292-4284-865D-8EDAAD5BA28CQ39124540-B5DDEBC8-B0EC-41A3-AE67-BB9BEE0D71F7Q41987899-AA59378F-4D0B-4BE7-B492-B04B2DFF116FQ44066663-A73D1C07-CD7B-4E38-A133-8BE54279A485Q45904521-357291A8-ECAC-4D5D-86D9-50855F8A4992Q58789014-2D93058F-099C-4428-B479-F59A0CE9553BQ61945700-D497D2F2-7B60-437E-9E08-846ACB85F3C3Q63197317-ADFBB597-F7C9-4E6B-995D-DF5855D8634DQ63197319-DF991156-EF63-4025-B169-47E4FACD770EQ63197320-313B5EE9-40D1-4084-A020-7945DF53A274Q63197321-C0CB39D4-3E78-41D8-BC6B-111576CE05B1Q63197322-0598E617-D529-489F-8663-22B126FEA3B8
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Aldona Dlugosz
@ast
Aldona Dlugosz
@en
Aldona Dlugosz
@es
Aldona Dlugosz
@nl
type
label
Aldona Dlugosz
@ast
Aldona Dlugosz
@en
Aldona Dlugosz
@es
Aldona Dlugosz
@nl
prefLabel
Aldona Dlugosz
@ast
Aldona Dlugosz
@en
Aldona Dlugosz
@es
Aldona Dlugosz
@nl
P106
P21
P31
P496
0000-0003-3540-2571